Acetaminophen, Caffeine and Dihydrocodeine Bitartrate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Larken Laboratories Inc.. The primary component is Acetaminophen; Caffeine; Dihydrocodeine Bitartrate.
Product ID | 68047-720_9018628a-7f4f-1fbd-e053-2995a90a41f5 |
NDC | 68047-720 |
Product Type | Human Prescription Drug |
Proprietary Name | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate |
Generic Name | Acetaminophen, Caffeine And Dihydrocodeine Bitartrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-10-04 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA204209 |
Labeler Name | Larken Laboratories Inc. |
Substance Name | ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE |
Active Ingredient Strength | 325 mg/1; mg/1; mg/1 |
Pharm Classes | Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CIII |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-10-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA204209 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-10-04 |
Ingredient | Strength |
---|---|
ACETAMINOPHEN | 325 mg/1 |
SPL SET ID: | 28bb5975-32f6-414a-84ed-c376da575e3f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
68047-720 | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate |
71993-300 | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate |
70362-730 | DVORAH | acetaminophen, caffeine and dihydrocodeine bitartrate |
70569-152 | DVORAH | acetaminophen, caffeine and dihydrocodeine bitartrate |